Scientific article
English

Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial

Published in

Drugs & Aging, vol. 33, no. 9, p. 665-673

Publication date

2016

Abstract

Few studies have examined the effect of anti-dementia drugs (i.e., acetylcholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists) on gait performance. Past studies have focused on the stride time (i.e., gait cycle duration) but not on the mental imagery of gait.

Keywords

  • Aged
  • Aged
  • 80 and over
  • Alzheimer Disease/drug therapy/physiopathology/psychology
  • Cholinesterase Inhibitors/administration & dosage/adverse effects/therapeutic use
  • Cohort Studies
  • Female
  • Gait/drug effects
  • Geriatric Assessment
  • Humans
  • Imagination/physiology
  • Male
  • Memantine/administration & dosage/adverse effects/therapeutic use
  • Receptors
  • N-Methyl-D-Aspartate/antagonists & inhibitors
  • Spatio-Temporal Analysis
  • Task Performance and Analysis
  • Walking/physiology/psychology

Citation (ISO format)

BEAUCHET, Olivier et al. Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial. In: Drugs & Aging, 2016, vol. 33, n° 9, p. 665–673. doi: 10.1007/s40266-016-0391-0

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1170-229X
470views
0downloads

Technical informations

Creation

23/08/2017 13:56:00

First validation

23/08/2017 13:56:00

Update

13/10/2025 19:34:33

Status update

15/03/2023 02:23:03

Last indexation

10/11/2026 17:26:08
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated